Wang G, Zhang Q, Song Y, Wang X, Guo Q, Zhang J, Li J, Han Y, Miao Z, Li F
Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang 110001, China.
Department of Pathology, China Medical University, Shenyang 110001, China.
Cell Death Dis. 2015 Mar 12;6(3):e1682. doi: 10.1038/cddis.2015.50.
Actin protrusion at the cell periphery is central to the formation of invadopodia during tumor cell migration and invasion. Although RUFY3 (RUN and FYVE domain containing 3)/SINGAR1 (single axon-related1)/RIPX (Rap2 interacting protein X) has an important role in neuronal development, its pathophysiologic role and relevance to cancer are still largely unknown. The purpose of this study was to elucidate the molecular mechanisms by which RUFY3 involves in gastric cancer cell migration and invasion. Here, our data show that overexpression of RUFY3 leads to the formation of F-actin-enriched protrusive structures at the cell periphery and induces gastric cancer cell migration. Furthermore, P21-activated kinase-1 (PAK1) interacts with RUFY3, and promotes RUFY3 expression and RUFY3-induced gastric cancer cell migration; inhibition of PAK1 attenuates RUFY3-induced SGC-7901 cell migration and invasion. Importantly, we found that the inhibitory effect of cell migration and invasion is significantly enhanced by knockdown of both PAK1 and RUFY3 compared with knockdown of RUFY3 alone or PAK1 alone. Strikingly, we found significant upregulation of RUFY3 in gastric cancer samples with invasive carcinoma at pathologic TNM III and TNM IV stages, compared with their non-tumor counterparts. Moreover, an obvious positive correlation was observed between the protein expression of RUFY3 and PAK1 in 40 pairs of gastric cancer samples. Therefore, these findings provide important evidence that PAK1 can positively regulate RUFY3 expression, which contribute to the metastatic potential of gastric cancer cells, maybe blocking PAK1-RUFY3 signaling would become a potential metastasis therapeutic strategy for gastric cancer.
肌动蛋白在细胞周边的突出对于肿瘤细胞迁移和侵袭过程中侵袭性伪足的形成至关重要。尽管RUFY3(含RUN和FYVE结构域的蛋白3)/SINGAR1(单轴突相关蛋白1)/RIPX(Rap2相互作用蛋白X)在神经元发育中具有重要作用,但其病理生理作用及与癌症的相关性仍 largely未知。本研究的目的是阐明RUFY3参与胃癌细胞迁移和侵袭的分子机制。在此,我们的数据表明,RUFY3的过表达导致细胞周边形成富含F-肌动蛋白的突出结构,并诱导胃癌细胞迁移。此外,P21激活激酶-1(PAK1)与RUFY3相互作用,促进RUFY3表达及RUFY3诱导的胃癌细胞迁移;抑制PAK1可减弱RUFY3诱导的SGC-7901细胞迁移和侵袭。重要的是,我们发现与单独敲低RUFY3或PAK1相比,同时敲低PAK1和RUFY3对细胞迁移和侵袭的抑制作用显著增强。令人惊讶的是,我们发现与非肿瘤对应物相比,病理TNM III和TNM IV期浸润性癌的胃癌样本中RUFY3显著上调。此外,在40对胃癌样本中观察到RUFY3和PAK1的蛋白表达之间存在明显的正相关。因此,这些发现提供了重要证据,即PAK1可正向调节RUFY3表达,这有助于胃癌细胞的转移潜能,也许阻断PAK1-RUFY3信号通路将成为胃癌潜在的转移治疗策略。